Newsweek (11/16, Clarke-Billings) reports, “Black women are nearly twice as likely to be diagnosed with advanced breast cancer as white women in England, according to Cancer Research UK and Public Health England.” About “25 percent of black African women and 22 percent of black Caribbean women diagnosed with breast cancer are picked up at stage three and four, compared to 13 percent of white British women.”
The Radiology Business Journal (11/16, Maglaya) reports that “patients fighting breast cancer already face taxing physical and emotional obstacles – but” research indicates “they are also facing an increase in the number of imaging appointments.” In a statement, Richard Bleicher, MD, said, “The number of days patients are having mammograms, MRIs, and ultrasounds is going up steadily year by year. They’re having imaging done more frequently on separate dates during the preoperative interval than ever before.”
Diagnostic Imaging (11/15) reports, “When radiologists compare two or more prior mammograms, screening mammography recall rates are significantly reduced,” researchers found after analyzing data from “46,288 consecutive screening mammograms performed at the department of radiology and biomedical imaging, University of California, San Francisco, for 22,792 women.” The findings were published in the American Journal of Roentgenology.
Aunt Minnie (11/14, Rush) reports, “In its ongoing efforts to improve breast cancer detection rates, the” FDA “has announced that it plans to use its Mammography Quality Standards Act (MQSA) inspection program to increase mammography image quality through a new venture it’s calling Enhancing Quality Using the Inspection Program.”